BOOMING: Charles and Cathy Lineberry left positions at Glaxo Wellcome to form their own CRO.
But he finds the frustrations of working in a "very large, heavily structured organization" now are gone for him. He thinks this is the major reason many experienced corporate executives have chosen to leave industry and form their own small consultant CROs.
Because they wanted to form a company with "the kind of atmosphere that we would want to work in," pharmaceutical marketing and public-relations specialist Cathy Frieden Lineberry and her husband, clinical pharmacologist Charles Lineberry, took Glaxo Wellcome PLC's severance option and early retirement option, respectively. The next day, they began a small pharmaceutical research and consulting company and CRO, Lineberry Research Associates. Along with two other former researchers from the Raleigh, N.C., pharmaceutical firm, they set up shop in their home on July 1 of this year, offering particular expertise in the central ...
